NASDAQ
bluebird bio, Inc. (BLUE) has a current ratio of 0.48x as of Monday, May 25, 2026. This represents a 82.27% decrease compared to its 12-month average of 2.71x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.